RedHill Biopharma RDHL
NASDAQ RDHL
$0.49 +0.01 (+1.34%)
As of: Oct 1, 2026 · 2:04 PM EDT

RedHill Biopharma (RDHL) Long-Term Deferred Tax (2017)

Updated

RedHill Biopharma's Long-Term Deferred Tax was $76 million in the quarter ended Dec 31, 2017.

Analysis

RedHill Biopharma (RDHL) Long-Term Deferred Tax (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 RedHill Biopharma 7.09 Mn 7.09 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 76.00 Mn
API Access

RedHill Biopharma Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=RDHL&period=max&api_key=YOUR_API_KEY